| P50 | author | Olle Ringden | Q89625226 |
| | Behnam Sadeghi | Q53142824 |
| P2093 | author name string | Jonas Mattsson | |
| | Mats Remberger | |
| | Britt-Marie Svahn | |
| | Gianluca Moretti | |
| | Brita Eriksson | |
| | Sigrun Finnbogadottir | |
| P2860 | cites work | Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment | Q70239474 |
| | Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings | Q72010919 |
| | Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation | Q72047313 |
| | Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation | Q72262827 |
| | A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group | Q72384744 |
| | Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia | Q72809667 |
| | Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation | Q73903987 |
| | Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases | Q74106097 |
| | Costs of allogeneic hematopoietic stem cell transplantation | Q79955703 |
| | Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition | Q81072219 |
| | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| | A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation | Q33573529 |
| | Reduced mortality after allogeneic hematopoietic-cell transplantation | Q34472861 |
| | Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? | Q34743469 |
| | Immunobiology of acute graft-versus-host disease | Q35558501 |
| | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia | Q35976578 |
| | HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide | Q37078261 |
| | Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 |
| | The allogeneic graft-versus-cancer effect. | Q37593125 |
| | Hotel-based ambulatory care for complex cancer patients: a review of the University College London Hospital experience | Q38010475 |
| | One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation | Q39139747 |
| | Protective environment for marrow transplant recipients: a prospective study | Q39220923 |
| | Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts | Q39244446 |
| | Short natural sleep is associated with higher T cell and lower NK cell activities | Q39760140 |
| | Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care | Q40572369 |
| | Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial | Q40611081 |
| | Strict protective isolation in allogenic bone marrow transplantation: effect on infectious complications, fever and graft versus host disease | Q40802109 |
| | Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer | Q40994796 |
| | Pretransplant herpesvirus serology and acute graft-versus-host disease | Q43455328 |
| | Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital | Q43486658 |
| | Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease | Q43836185 |
| | Herpes-virus immunity and acute graft-versus-host disease | Q44215935 |
| | Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation | Q44533357 |
| | Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease | Q45085421 |
| | A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. | Q46200207 |
| | Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation | Q47416112 |
| | Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. | Q50856033 |
| | Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) | Q51608296 |
| | Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. | Q53313339 |
| | Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. | Q53353053 |
| | Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. | Q53665940 |
| | Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study | Q58789014 |
| | Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation | Q67919340 |
| | Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras | Q68753387 |
| | Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial | Q69499226 |
| | Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora | Q70043938 |
| | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 |
| P433 | issue | 4 | |
| P304 | page(s) | 478-485 | |
| P577 | publication date | 2017-11-15 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation | |
| P478 | volume | 107 | |